Genpharm’s Board is comprised of Senior Executives from several industries including R&D, Biotech, Pharmaceutical, Financial Services and Management. Through their Executive Board memberships on several organizations and vast management experience, they provide strategic guidance to Genpharm and its partners in MENA.

With more than 22 years of regional experience in Senior Executive roles, Karim launched and managed operations for several Biotech and rare disease companies. An expert in emerging markets, in particular in the MENA region, Turkey, South East Europe and Russia. Karim is an active member of several industry associations and business councils.

Mr. Karim Smaira

CEO and Co-Founder
Over 33 years of regional Pharma experience in Senior Executive roles within MNCs & Distributors. Former Managing Director of Farbro Group and Examon MENA. Kamel is also the former General Manager of Janssen Cilag ME. He has been Honored by Rotary several times as Paul Harris Fellow for meeting outstanding personal and professional standards, as well as his charitable work.

Mr. Kamel Ghammachi

Chairman and Co-Founder
Chairman of Santhera Pharmaceuticals and Executive Board Member of Stallergenes Greer PLC. Elmar is also a Board of Director Member of Jazz Pharmaceuticals and the former General Partner and Member of the Executive Board at Merck KGaA. Previously held senior positions in Marketing, Strategy & BD at UCB, Sanofi & others.

Mr. Elmar Schnee

Chairman of Santhera Pharmaceuticals
Board Member at Calmaste Sciences and Former CEO of Sterling Natural Science and Sopherion Therapeutics. Dr Samy is the Former Faculty member Harvard Medical School and The Children’s Hospital-Boston. A published author of several scientific publications in prestigious journals including Science and JBC and holder of multiple international patents as a result of his scientific research work.

Mr. Samy Ashkar

Former CEO of Sterling Natural Science
Over 20 years of experience in bringing rare disease drugs to market. Former Member of the Board of American Alliance of Regenerative Medicine (ARM). Former Chief Commercial Officer PTC Therapeutics and Former Head EMEA region Shire Human Genetic Therapies. Former Commercial Director EMEA for Chiron & Pathogenesis.

Mr. Mark Rothera

Former CEO of Orchard Therapeutics